Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking a Principal Scientist to drive innovative research in cardiometabolic diseases. This pivotal role involves executing translational biology plans using cutting-edge computational platforms to develop new therapies. The ideal candidate will possess deep expertise in obesity and inflammation, with a strong background in drug discovery. You will collaborate with multidisciplinary teams to design experiments, validate biomarkers, and contribute to the advancement of drug candidates through the pipeline. Join a dynamic team dedicated to transforming healthcare and making a meaningful impact on patients' lives.
Lexington, Massachusetts, United States
About Us
Valo Health is a technology company that is integrating human-centric data and AI-powered technology to accelerate the creation of life-changing drugs for more patients faster. Valo was created with the belief that the drug discovery and development process can and should be faster and less expensive, with a much higher probability of success. We are using models early to fail less often, executing clinical trials to add valuation to the company, and generating fit-for-purpose data to feed back into Valo’s Opal Computational Platform as we reinvent drug discovery and development from the ground up. Disease doesn’t wait, so neither can we.
We are a multi-disciplinary team of experts in science, technology, and pharmaceuticals united in our mission to achieve better drugs for patients faster. Valo is committed to hiring diverse talent, prioritizing growth and development, fostering an inclusive environment, and creating opportunities to bring together a group of different experiences, backgrounds, and voices to work together. We achieve the widest-ranging impact when we leverage our broad backgrounds and perspectives to accelerate a new frontier in health. Valo seeks to become the catalyst for the pharmaceutical industry and drive the digital transformation of the industry. Are you ready to join us?
About the Role...
Valo is looking for a Principal Scientist to play a pivotal role in executing the wet lab translational biology plans for targets that have been identified using Valo’s human-centric Opal computational platform. This position requires deep expertise in the biology of obesity and/or cardiometabolic disease ideally with additional experience in inflammation. This ideal candidate will have experience in drug discovery and a passion for translating human data insights to develop new therapies for complex diseases at the bench. In this role, you will be responsible for helping to design and execute program related translational biology plans to demonstrate in vitro/in vivo correlation including PK/PD, profiling of cells and tissues whether by omics, imaging, or other targeted and untargeted methods, and demonstration for key cellular or in vivo biomarkers. This role will be critical to build confidence in translation of candidate drug targets to diseases of interest and in supporting their progression through the pipeline. You will closely collaborate with subject matter experts, computational scientists, other wetlab biologists, and tissue-engineers. You will contribute to delivering validation data packages from your efforts and presenting to internal and external stakeholders. You will participate as a subject matter expert collaboration with Valo’s target discovery team where appropriate.
What You’ll Do…
What You Bring…
You May Also Bring…
More on Valo
Valo Health, LLC (“Valo”) is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative diseases. Founded by Flagship Pioneering and headquartered in Lexington, MA. Valo also has offices in New York, NY. To learn more, visit www.valohealth.com.